774 related articles for article (PubMed ID: 16703451)
1. Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002).
Anderson WF; Jatoi I; Devesa SS
Breast Cancer Res Treat; 2006 Oct; 99(3):333-40. PubMed ID: 16703451
[TBL] [Abstract][Full Text] [Related]
2. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Glass AG; Lacey JV; Carreon JD; Hoover RN
J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
[TBL] [Abstract][Full Text] [Related]
4. Trends in breast cancer by race and ethnicity: update 2006.
Smigal C; Jemal A; Ward E; Cokkinides V; Smith R; Howe HL; Thun M
CA Cancer J Clin; 2006; 56(3):168-83. PubMed ID: 16737949
[TBL] [Abstract][Full Text] [Related]
5. The full potential of breast cancer screening use to reduce mortality has not yet been realized in the United States.
Schootman M; Jeffe D; Reschke A; Aft R
Breast Cancer Res Treat; 2004 Jun; 85(3):219-22. PubMed ID: 15111759
[TBL] [Abstract][Full Text] [Related]
6. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
[TBL] [Abstract][Full Text] [Related]
7. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
[TBL] [Abstract][Full Text] [Related]
8. Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.
Welch HG; Prorok PC; O'Malley AJ; Kramer BS
N Engl J Med; 2016 Oct; 375(15):1438-1447. PubMed ID: 27732805
[TBL] [Abstract][Full Text] [Related]
9. Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?
Taplin SH; Ichikawa L; Yood MU; Manos MM; Geiger AM; Weinmann S; Gilbert J; Mouchawar J; Leyden WA; Altaras R; Beverly RK; Casso D; Westbrook EO; Bischoff K; Zapka JG; Barlow WE
J Natl Cancer Inst; 2004 Oct; 96(20):1518-27. PubMed ID: 15494602
[TBL] [Abstract][Full Text] [Related]
10. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data.
Swedish Organised Service Screening Evaluation Group
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):45-51. PubMed ID: 16434585
[TBL] [Abstract][Full Text] [Related]
11. Reduction of Advanced Breast Cancer Stages at Subsequent Participation in Mammography Screening.
Weigel S; Heindel W; Heidrich J; Heidinger O; Hense HW
Rofo; 2016 Jan; 188(1):33-7. PubMed ID: 26485700
[TBL] [Abstract][Full Text] [Related]
12. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. United Kingdom Association of Cancer Registries.
Quinn M; Allen E
BMJ; 1995 Nov; 311(7017):1391-5. PubMed ID: 8520272
[TBL] [Abstract][Full Text] [Related]
13. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
Autier P; Boniol M; Koechlin A; Pizot C; Boniol M
BMJ; 2017 Dec; 359():j5224. PubMed ID: 29208760
[No Abstract] [Full Text] [Related]
15. Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography.
Jacklyn G; McGeechan K; Irwig L; Houssami N; Morrell S; Bell K; Barratt A
Breast Cancer Res Treat; 2017 Dec; 166(3):843-854. PubMed ID: 28822001
[TBL] [Abstract][Full Text] [Related]
16. Effect of three decades of screening mammography on breast-cancer incidence.
Bleyer A; Welch HG
N Engl J Med; 2012 Nov; 367(21):1998-2005. PubMed ID: 23171096
[TBL] [Abstract][Full Text] [Related]
17. Incidence of and treatment for ductal carcinoma in situ of the breast.
Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
[TBL] [Abstract][Full Text] [Related]
18. Shifting breast cancer trends in the United States.
Anderson WF; Reiner AS; Matsuno RK; Pfeiffer RM
J Clin Oncol; 2007 Sep; 25(25):3923-9. PubMed ID: 17679726
[TBL] [Abstract][Full Text] [Related]
19. Reduction in late-stage breast cancer incidence in the mammography era: Implications for overdiagnosis of invasive cancer.
Helvie MA; Chang JT; Hendrick RE; Banerjee M
Cancer; 2014 Sep; 120(17):2649-56. PubMed ID: 24840597
[TBL] [Abstract][Full Text] [Related]
20. Recent trends in U.S. breast cancer incidence, survival, and mortality rates.
Chu KC; Tarone RE; Kessler LG; Ries LA; Hankey BF; Miller BA; Edwards BK
J Natl Cancer Inst; 1996 Nov; 88(21):1571-9. PubMed ID: 8901855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
